​

Monopar Therapeutics Ownership | Who Owns Monopar Therapeutics?

OverviewForecastFinancialsChart

Monopar Therapeutics Ownership Summary

Monopar Therapeutics is owned by 4.13% institutional investors, 34.38% insiders, and 61.49% retail investors. Millennium management is the largest institutional shareholder, holding 1.22% of MNPR shares. iShares Russell 2000 ETF is the top mutual fund, with 1.45% of its assets in Monopar Therapeutics shares.

MNPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMonopar Therapeutics4.13%34.38%61.49%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management194.30K1.22%$145.34K
Geode capital management60.04K0.38%$44.91K
Virtu financial18.84K0.12%$14.00K
Wells fargo & company/mn2.50K0.02%$1.82K
Bank of america corp /de/561.000.00%$410.00
Ubs group---
Gerber---
Newedge advisors---
Hrt financial lp---
Fmr---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial18.84K0.00%$14.00K
Millennium management194.30K0.00%$145.34K
Two sigma securities---
Federation des caisses desjardins du quebec---
Bank of america corp /de/561.00-$410.00
Rappaport reiches capital management---
Ubs group---
Gerber---
Newedge advisors---
Wells fargo & company/mn2.50K-$1.82K

Top Buyers

HolderShares% AssetsChange
Geode capital management60.04K-18.84K
Millennium management194.30K0.00%1.92K
Wells fargo & company/mn2.50K-963.00
Bank of america corp /de/561.00-61.00
Federation des caisses desjardins du quebec---80.00

Top Sellers

HolderShares% AssetsChange
Two sigma securities---47.06K
Vanguard group---45.17K
Hrt financial lp---32.11K
Gerber---28.00K
Rappaport reiches capital management---10.70K

Sold Out

HolderChange
Federation des caisses desjardins du quebec-80.00
Morgan stanley-800.00
Ubs group-2.57K
Newedge advisors-3.00K
Fmr-5.50K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253488.89%2,886,01911.94%48.93%2353.33%5400.00%
Dec 31, 202418200.00%2,578,29516314.94%6341848.65%151400.00%1-80.00%
Sep 30, 20246-50.00%15,707-96.24%-16.30%1-83.33%5400.00%
Jun 30, 202412-20.00%418,1625.80%232.01%6-14.29%1-50.00%
Mar 31, 2024157.14%395,22845.63%277.37%7-12.50%2-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Russell 2000 ETF88.55K1.45%615.00
Vanguard Institutional Extnd Mkt Idx Tr55.47K0.91%-
iShares Russell 2000 Growth ETF34.77K0.57%86.00
Fidelity Extended Market Index23.40K0.38%-105.00
State St Russell Sm Cap® Indx SL Cl I14.30K0.23%14.30K
NT R2000 Index Fund - NL9.84K0.16%9.84K
iShares Micro-Cap ETF9.09K0.15%-
Fidelity Total Market Index8.00K0.13%-
NT R2000 Index Fund - DC - NL - 37.84K0.13%7.84K
Extended Equity Market Fund K6.85K0.11%-137.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 02, 2025Tactic Pharma LLC-Sell$1.17M
Oct 28, 2024Radhakrishnan Karthik Chief Financial OfficerBuy$25.19K
Jun 20, 2024Cittadine Andrew Chief Operating OfficerBuy$15.25K
Jun 18, 2024Cittadine Andrew Chief Operating OfficerBuy$10.32K
Jun 13, 2024Cittadine Andrew Chief Operating OfficerBuy$10.92K

Insider Transactions Trends

DateBuySell
2025 Q2-1
2025 Q1--
2024 Q41-
2024 Q3--
2024 Q210-

MNPR Ownership FAQ

Who Owns Monopar Therapeutics?

Monopar Therapeutics shareholders are primarily institutional investors at 4.13%, followed by 34.38% insiders and 61.49% retail investors. The average institutional ownership in Monopar Therapeutics's industry, Biotech Stocks , is 63.84%, which Monopar Therapeutics falls below.

Who owns the most shares of Monopar Therapeutics?

Monopar Therapeutics’s largest shareholders are Millennium management (194.3K shares, 1.22%), Geode capital management (60.04K shares, 0.38%), and Virtu financial (18.84K shares, 0.12%). Together, they hold 1.71% of Monopar Therapeutics’s total shares outstanding.

Does Blackrock own Monopar Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Monopar Therapeutics.

Who is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 18.84K Monopar Therapeutics shares, valued at 14K$.

Who is the top mutual fund holder of Monopar Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Monopar Therapeutics shares, with 1.45% of its total shares outstanding invested in 88.55K Monopar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools